Good Hope Eye Department

Good Hope Hospital Eye Clinic
====
    home |
| |
| | |
|
 
 

ARMD and the other eye
David Kinshuck & Monique Hope-Ross


See also

'Low vision' section,
support  

RNIB page (link)
Hints & Coping
Macula degeneration: pathology
dry ARMD
wet ARMD

Lucentis treatment program
myopic macula degeneration

Macula degeneration: understanding
Risk simulation
Diabetic maculopathy (link)
Coping with poor sight in one eye
Magnification

Low Vision Assessment
Rehabilitation & local services
Birmingham Focus (link)
PDT program
Low vision Gateway (US site)

Walsall Eyes Newsletter
Macular Disease Society
New drugs..Lucentis, Macugen, Avastin  
A table comparing drugs
Studies published and in progress

Audio interview (NEJM)
Rehabilitation Centre
rnib.talkandsupport

Links
Abbreviations

education

Large diagram 1
Large diagram 2
Animation full size
Lucentis animation

Animation (link)
Case 1 macula for students: 400kb
Case 2 macula: hard drusen
Case CSR
Case 4: wet macular degn (CCNV)
Case 5: occult CNV
Case 6 soft drusen
Atlas...Bests, Haem
SWF file for laptops of light/macular animation: 1mb
epidemiology
US Aging Times Review

Genes
treatment advances
dry ARMD (link)


ARMD and risks for the other eye
Unfortunately age related macular degeneration can affect the other eye. See healthy lifestyle above: this may help. If you do notice a change in your sight, see distortion above. See a search . Risk from drusen.
  • The atrophic or dry type usually does occur in both eyes, but remember this generally gets only slowly worse.
  • There may be a gap of years before the process begins in the second eye.

Concerning neovascular or wet type ARMD....

  • The neovascular or wet type can also affect the other eye, at an overall rate of 90% over the next 5 years.
  • High blood pressure, one large drusen near the fovea, 5 drusen in the macular area, and retinal pigment epithelial changes each contribute to this 90%.
  • So if you have only one of these risk factors, such as 5 drusen and a low blood pressure and don't smoke, then the progression rate is 90/4, that is about 23% over a 5 year period . If you have 2 risk factors, 45%.
  • But if you have 2 risk factors (45% 5 year risk) and your partner smokes 20/day, your risk is 45 x2 = 90% over 5 years...see immediately below.
  • The figure is 4 times higher for smokers, and twice as high for passive smokers. (If smoking at 20 cigarettes/day.)
  • the active phase may last 3-12 months, with the sight deteriorating during this time, and after that they may be little change. Treatment (laser & drugs) is needed during the active phase, and is of no help later. Anti-VEGF treatment may be needed for 2 years.
 
 


----------------------Eye pages website feedback -----this page edited October 2008----------------------